Opendata, web and dolomites

BioBalanced

Feasibility study for Bioapplications – BioBalanced Farm probiotic

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BioBalanced project word cloud

Explore the words cloud of the BioBalanced project. It provides you a very rough idea of what is the project "BioBalanced" about.

efficacy    annually    home    16    occurs    enter    market    cows    units    misted    mutation    strengthens    improves    lives    700    replication    firstly    followed    medications    antibiotics    entry    infections    substitute    worldwide    odours    goats    plans    prevent    pig    agriculture    rapid    service    naturally    expanding    die    transformed    size    pathogenic    million    147    generally    attributed    2017    prevalent    strategy    total    facility    welfare    47    331    poultry    mass    environment    immune       meat    countries    netherlands    overuse    commercialisation    sheep    resistance    24    meters    square    farm    farmers    spain    industrially    germany    34    millions    misuse    biobalanced    medicine    endangering    bad    cow    probiotic    quality    heavily    overused    probiotics    excludes    bacteria    solution    demand    saved    chemical    antibiotic    patients    44    e8    denmark    stag    preparation    lsus    emergence    validated    reduces    crisis    88    fight    regions    pigs    successful    livestock    consequently    caused    blend    eurostat    resistant    bioapplications    26    prototype       markets    hazardous    belgium    trl    scaling    farms   

Project "BioBalanced" data sheet

The following table provides information about the project.

Coordinator
UAB BIOAPPLICATIONS 

Organization address
address: TITUPIO G 3
city: SAKIU RAJ JOGINISKIAI
postcode: 71215
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Lithuania [LT]
 Project website http://bioapplications.dk
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-07-01   to  2018-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UAB BIOAPPLICATIONS LT (SAKIU RAJ JOGINISKIAI) coordinator 50˙000.00

Map

 Project objective

A rapid emergence of resistant bacteria occurs worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives. The antibiotic resistance crisis has been attributed to the overuse and misuse of these medications. 700 000 patients die annually as a result of infections caused by antibiotic resistant bacteria. Due to a growing demand to substitute medicine and hazardous chemical usage in agriculture, Bioapplications developed the BioBalanced Farm Probiotic – a unique probiotics blend, which is misted in the facility, naturally excludes pathogenic bacteria and prevent mutation and development of resistant bacteria. The Solution also strengthens immune system, improves the welfare and increases the mass of the livestock, reduces bad odours, and generally improves a quality of meat. Consequently, farmers are able to fight. According to Eurostat, there were 331.16 million Livestock Units (LSUs) in 2017 – 44.47% were pigs, 26.9% were cows, 26.3% were sheep’s and 3.9% were goats. Since pigs are the most prevalent in Europe and antibiotics are heavily overused in pig farms, the commercialisation of the solution will be firstly focused on pig farms. With a total of 147.24 M pigs in EU-E8, the total available market size for BioBalanced Farm probiotic is 88.34 M square meters. Bioapplications will enter the market by targeting large pig farms in home market Denmark, followed by Spain, Germany, the Netherlands and Belgium. After a successful commercialisation, Bioapplications plans to scale-up by expanding into other EU regions and providing the service to poultry and cows farms. Commercialisation strategy includes three steps: preparation for market entry (home markets), market replication (large pig farms in target countries) and scaling-up (large pigs/poultry/cow farms in other EU countries). The Solution developed by Bioapplications is currently at TRL 6: prototype that is validated in industrially relevant environment stag

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOBALANCED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOBALANCED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

ADAPTOS (2019)

ADAPTOS - Changing the way bone voids are treated

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More